{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:07:26Z","timestamp":1791317246679,"version":"4.3.1"},"update-to":[{"DOI":"10.1002\/14651858.cd013767","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T00:00:00Z","timestamp":1673568000000}}],"reference-count":135,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd013767.pub2","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T16:47:59Z","timestamp":1673628479000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Foetal haemoglobin inducers for reducing blood transfusion in non-transfusion-dependent beta-thalassaemias"],"prefix":"10.1002","volume":"2023","author":[{"given":"Wai Cheng","family":"Foong","sequence":"additional","affiliation":[{"name":"Department of Paediatrics; RCSI & UCD Malaysia Campus (formerly Penang Medical College); George Town Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C Khai","family":"Loh","sequence":"additional","affiliation":[{"name":"Department of Paediatrics; Universiti Kebangsaan Malaysia Medical Centre; 56000 Cheras Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline J","family":"Ho","sequence":"additional","affiliation":[{"name":"Department of Paediatrics; RCSI & UCD Malaysia Campus (formerly Penang Medical College); George Town Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris SC","family":"Lau","sequence":"additional","affiliation":[{"name":"Department of Paediatrics; Universiti Kebangsaan Malaysia Medical Centre; 56000 Cheras Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,1,13]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD013767.pub2-BIB0001|cit1","first-page":"191","article-title":"Optimizing the dose of hydroxyurea in thalassemia intermedia","volume":"28","author":"Bohara","year":"2012","journal-title":"Indian Journal Hematology Blood Transfusion"},{"issue":"1","key":"10.1002\/14651858.CD013767.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3109\/03630269.2013.845844","article-title":"Optimizing the dose of hydroxyurea therapy for patients with \u03b2-thalassemia intermedia (Hb E- \u03b2-thalassemia): a single center study from Eastern India","volume":"38","author":"Bohara","year":"2014","journal-title":"Hemoglobin"},{"issue":"21","key":"10.1002\/14651858.CD013767.pub2-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"4280","DOI":"10.1182\/blood.V116.21.4280.4280","article-title":"HQK-1001 is well tolerated and augments hemoglobin F and hemoglobin levels in patients with beta thalassemia intermedia","volume":"116","author":"Fuchareon","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1002\/14651858.CD013767.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/bjh.12304","article-title":"A randomized phase I\/II trial of HQK-1001, an oral fetal globin gene inducer, in \u03b2-thalassaemia intermedia and HbE\/\u03b2-thalassaemia","volume":"161","author":"Fucharoen","year":"2013","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD013767.pub2-BIB0005|cit5","unstructured":"Comparison of the efficacy and safety of herbal product (Resveratrol) with hydroxyurea (HU) in non- transfusion- dependent B-thalassemia intermedia en.irct.ir\/trial\/17784"},{"issue":"10","key":"10.1002\/14651858.CD013767.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s00277-018-3392-8","article-title":"Efficacy and safety of resveratrol, an oral hemoglobin F-augmenting agent, in patients with beta-thalassemia intermedia","volume":"97","author":"Haghpanah","year":"2018","journal-title":"Annals of Hematology"},{"issue":"S1","key":"10.1002\/14651858.CD013767.pub2-BIB0007|cit7","first-page":"336","article-title":"Efficacy and safety of resveratrol, an oral HbF augmenting agent, in patients with beta thalassemia intermedia","volume":"2","author":"Karimi","year":"2018","journal-title":"Hemasphere"},{"key":"10.1002\/14651858.CD013767.pub2-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1007\/s12288-019-01207-5","article-title":"Efficacy of thalidomide and hydroxyurea as HB F inducer in non-transfusion dependent thalassemia","volume":"35","author":"Jain","year":"2019","journal-title":"Indian Journal of Hematology and Blood Transfusion"},{"issue":"1","key":"10.1002\/14651858.CD013767.pub2-BIB0009|cit9","first-page":"S52","article-title":"Decitabine vs hydroxyurea on hemoglobin F induction in patients of E beta thalassemia","volume":"35","author":"Jha","year":"2019","journal-title":"Indian Journal of Hematology & Blood Transfusion"},{"issue":"1","key":"10.1002\/14651858.CD013767.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1600-0609.2009.01356.x","article-title":"Effect of combination therapy of hydroxyurea with l-carnitine and magnesium chloride on hematologic parameters and cardiac function of patients with beta-thalassemia intermedia","volume":"84","author":"Karimi","year":"2010","journal-title":"European Journal of Haematology"},{"key":"10.1002\/14651858.CD013767.pub2-BIB0011|cit11","unstructured":"Combination therapy of hydroxyurea with L-carnitine and magnesium chloride in thalassemia intermedia clinicaltrials.gov\/ct2\/show\/NCT00809042"},{"key":"10.1002\/14651858.CD013767.pub2-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"7468979","DOI":"10.1155\/2016\/7468979","article-title":"Radix astragali stimulates p38 MARK phosphorylation in pediatric patients with beta-thalassemia","volume":"2016","author":"Lu","year":"2016","journal-title":"Evidence-based Complementary and Alternative Medicine"},{"issue":"5","key":"10.1002\/14651858.CD013767.pub2-BIB0013|cit13","first-page":"344","article-title":"Prospective clinical study of radix astragali and its compound prescription for treatment of \u03b2-thalassemia in children","volume":"14","author":"Lu","year":"2012","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi (Chinese Journal of Contemporary Pediatrics)"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD013767.pub2-BIB0014|cit14","first-page":"S505","article-title":"The role of hydroxyurea and valproic acid in the management of severe HbE- \u03b2 thalassaemia","volume":"30","author":"Biswas","year":"2014","journal-title":"Indian Journal of Hematology and Blood Transfusion"},{"issue":"7","key":"10.1002\/14651858.CD013767.pub2-BIB0015|cit15","first-page":"591","article-title":"Effect of yisuishengxue granule on gene expression in children with beta-thalassemia","volume":"25","author":"Chai","year":"2005","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"10.1002\/14651858.CD013767.pub2-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"1713897","DOI":"10.11155\/2016\/1713897","article-title":"Clinical effect and mechanism of Yisui Shengxue granules in thalassemia patients with mild, moderate, or severe anemia","volume":"2016","author":"Cheng","year":"2016","journal-title":"Evidence-based Complementary Alternative Medicine"},{"issue":"6","key":"10.1002\/14651858.CD013767.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/ejh.12182","article-title":"Therapeutic superiority and safety of combined hydroxyurea with recombinant human erythropoietin over hydroxyurea in young \u03b2-thalassemia intermedia patients","volume":"91","author":"Elalfy","year":"2013","journal-title":"European Journal of Haematology"},{"issue":"11","key":"10.1002\/14651858.CD013767.pub2-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.11248\/bpb.30.2084","article-title":"Clinical observation on YiSuiShengXue Granule on treating 156 patients with beta-thalassemia major and the molecular mechanism study","volume":"30","author":"Fang","year":"2007","journal-title":"Biological & Pharmaceutical Bulletin"},{"key":"10.1002\/14651858.CD013767.pub2-BIB0019|cit19","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2014.2856","article-title":"Radix astragali induces in vitro and in vivo synthesis of fetal hemoglobin in non-transfusion-dependent \u03b2-thalassemia: a preliminary study","volume":"Withdrawn","author":"Guo","year":"2014","journal-title":"Molecular Medicine Reports"},{"issue":"5","key":"10.1002\/14651858.CD013767.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s12185-016-2069-0","article-title":"Therapeutic effect of Colla corii asini on improving anemia and hemoglobin compositions in pregnant women with thalassemia","volume":"104","author":"Li","year":"2016","journal-title":"International Journal of Hematology"},{"key":"10.1002\/14651858.CD013767.pub2-BIB0021|cit21","unstructured":"Therapeutic effect of colla corii asini on improving anemia and hemoglobin composition in pregnant women with thalassemia clinicaltrials.gov\/ct2\/show\/NCT02772016"},{"issue":"1","key":"10.1002\/14651858.CD013767.pub2-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1749-6632.1998.tb10469.x","article-title":"Hydroxyurea therapy in thalassemia","volume":"850","author":"Loukopoulos","year":"1998","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"12","key":"10.1002\/14651858.CD013767.pub2-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1182\/blood-2013-11-538470","article-title":"A phase 2 trial of HQK-1001 in HbE-\u03b2 thalassemia demonstrates HbF induction and reduced anemia","volume":"123","author":"Patthamalai","year":"2014","journal-title":"Blood"},{"issue":"7","key":"10.1002\/14651858.CD013767.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s11655-018-2777-9","article-title":"Genomewide DNA methylation responses in patients with \u03b2-thalassemia treated with Yisui Shengxue granules (YSSXG)","volume":"25","author":"Cheng","year":"2019","journal-title":"Chinese Journal of Integrative Medicine"},{"key":"10.1002\/14651858.CD013767.pub2-BIB0025|cit25","unstructured":"Study of effects of YisuiShengxue granules on thalassemia (thalessemia) clinicaltrials.gov\/show\/NCT01549080"},{"issue":"3","key":"10.1002\/14651858.CD013767.pub2-BIB0026|cit26","first-page":"806","article-title":"Curative effects of hydroxyurea on the patients with \u03b2-thalassaemia intermadia","volume":"24","author":"Huang","year":"2016","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"10.1002\/14651858.CD013767.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"102544","DOI":"10.1016\/j.bcmd.2021.102544","article-title":"Comparison of efficacy and safety of thalidomide vs hydroxyurea in patients with Hb E-beta thalassemia - a pilot study from a tertiary care centre of India","volume":"88","author":"Jain","year":"2021","journal-title":"Blood Cells, Molecules & Diseases"},{"key":"10.1002\/14651858.CD013767.pub2-BIB0028|cit28","unstructured":"A phase 2 study to evaluate the safety and tolerability of IMR-687 in subjects with beta thalassemia clinicaltrials.gov\/ct2\/show\/NCT04411082"},{"issue":"2","key":"10.1002\/14651858.CD013767.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3736\/jcim20070207","article-title":"Treatment of beta-thalassemia with Bushen Yisui therapy: a randomized controlled trial","volume":"5","author":"Wu","year":"2007","journal-title":"Zhong Xi Yi Jie He Xue Bao (Journal of Chinese Integrative Medicine)"},{"issue":"8","key":"10.1002\/14651858.CD013767.pub2-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1182\/blood-2007-01-065201","article-title":"Thalidomide induces gamma-globin gene expression through increased reactive oxygen species-mediated p38MAPK signaling and histone H4 acetylation in adult erythropoiesis","volume":"110","author":"Aerbajinai","year":"2007","journal-title":"Blood"},{"issue":"3","key":"10.1002\/14651858.CD013767.pub2-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.hemonc.2017.02.002","article-title":"Hydroxyurea for non transfusion-dependent \u03b2-thalassemia: a systematic review and meta-analysis","volume":"10","author":"Algiraigri","year":"2017","journal-title":"Hematology\/Oncology and Stem Cell Therapy"},{"issue":"1","key":"10.1002\/14651858.CD013767.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1600-0609.2011.01620.x","article-title":"Comparative study of pulmonary circulation and myocardial function in patients with \u03b2-thalassemia intermedia with and without hydroxyurea, a case-control study","volume":"87","author":"Amoozgar","year":"2011","journal-title":"European Journal of Haematology"},{"issue":"3","key":"10.1002\/14651858.CD013767.pub2-BIB0033|cit33","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012064.pub2","article-title":"Hydroxyurea (hydroxycarbamide) for transfusion-dependent \u03b2-thalassaemia","author":"Ansari","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD013767.pub2-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s12185-018-2411-9","article-title":"Beta-thalassemia intermedia: a comprehensive overview and novel approaches","volume":"108","author":"Asadov","year":"2018","journal-title":"International Journal of Hematology"},{"issue":"3","key":"10.1002\/14651858.CD013767.pub2-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/1096-8652(200011)65:3&lt;227::aid-ajh9&gt;3.0.co;2-v","article-title":"Mechanism for fetal hemoglobin induction by hydroxyurea in sickle cell erythroid progenitors","volume":"65","author":"Baliga","year":"2000","journal-title":"American Journal of Hematology"},{"issue":"2","key":"10.1002\/14651858.CD013767.pub2-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1093\/ecam\/nem139","article-title":"Fetal hemoglobin inducers from the natural world: a novel approach for identification of drugs for the treatment of \u03b2-thalassemia and sickle-cell anemia","volume":"6","author":"Bianchi","year":"2009","journal-title":"Evidence-Based Complementary and Alternative Medicine: eCAM"},{"issue":"3","key":"10.1002\/14651858.CD013767.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2141.2007.06654.x","article-title":"Modern treatment of thalassaemia intermedia","volume":"138","author":"Borgna-Pignatti","year":"2007","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD013767.pub2-BIB0038|cit38","doi-asserted-by":"crossref","unstructured":"Botzenhardt S Felisi M Bonifazi D Del Vecchio GC Putti MC Kattamis A Long-term safety of deferiprone treatment in children from the Mediterranean region with beta-thalassemia major: the DEEP-3 multi-center observational safety study Haematologica 2018 103 1 e1 4 29079595","DOI":"10.3324\/haematol.2017.176065"},{"issue":"4","key":"10.1002\/14651858.CD013767.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1182\/blood-2003-01-0117","article-title":"Hydroxyurea can eliminate transfusion requirements in children with severe \u03b2-thalassemia","volume":"102","author":"Bradai","year":"2003","journal-title":"Blood"},{"issue":"10","key":"10.1002\/14651858.CD013767.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/j.1537-2995.2007.01399.x","article-title":"Decreased transfusion needs associated with hydroxyurea therapy in Algerian patients with thalassemia major or intermedia","volume":"47","author":"Bradai","year":"2007","journal-title":"Transfusion"},{"issue":"1","key":"10.1002\/14651858.CD013767.pub2-BIB0041|cit41","first-page":"58","article-title":"Thalassemia intermedia","volume":"80","author":"Camaschella","year":"1995","journal-title":"Haematologica"},{"issue":"1","key":"10.1002\/14651858.CD013767.pub2-BIB0042|cit42","first-page":"66","article-title":"Clinical experience of management of thalassemia: the Sardinian experience","volume":"33","author":"Cao","year":"1996","journal-title":"Seminars in Hematology"},{"issue":"9","key":"10.1002\/14651858.CD013767.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1182\/blood-2005-08-3430","article-title":"A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia","volume":"107","author":"Cappellini","year":"2006","journal-title":"Blood"},{"issue":"3","key":"10.1002\/14651858.CD013767.pub2-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"231","DOI":"10.5581\/1516-8484.20110059","article-title":"What influences Hb fetal production in adulthood?","volume":"33","author":"Carrocini","year":"2011","journal-title":"Revista Brasiliera de Hematologica e Hemoterapia"},{"issue":"16","key":"10.1002\/14651858.CD013767.pub2-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1182\/blood-2017-11-737411","article-title":"Hepcidin agonists as therapeutic tools","volume":"131","author":"Casu","year":"2018","journal-title":"Blood"},{"issue":"10","key":"10.1002\/14651858.CD013767.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1182\/blood.V79.10.2555.2555","article-title":"Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia","volume":"79","author":"Charache","year":"1992","journal-title":"Blood"},{"key":"10.1002\/14651858.CD013767.pub2-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"1713897","DOI":"10.1155\/2016\/1713897","article-title":"Clinical effect and mechanism of Yisui Shengxue granules in thalassemia patients with mild, moderate, or severe anemia","volume":"2016","author":"Cheng","year":"2016","journal-title":"Evidence-Based Complementary and Alternative Medicine"},{"key":"10.1002\/14651858.CD013767.pub2-BIB0048|cit48","unstructured":"Deeks JJ Higgins JP Altman DG Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook"},{"issue":"1","key":"10.1002\/14651858.CD013767.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"e2017018","DOI":"10.4084\/mjhid.2017.018","article-title":"\u03b2-thalassemia distribution in the old world: an ancient disease seen from a historical standpoint","volume":"9","author":"De Sanctis","year":"2017","journal-title":"Mediterranean Journal of Hematology and Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD013767.pub2-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"3905","DOI":"10.1182\/blood.v99.11.3905","article-title":"Maintenance of elevated fetal hemoglobin levels by decitabine during dose interval treatment of sickle cell anemia","volume":"99","author":"DeSimone","year":"2002","journal-title":"Blood"},{"issue":"12","key":"10.1002\/14651858.CD013767.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1007\/s00277-014-2154-5","article-title":"Response to hydroxycarbamide in pediatric \u03b2-thalassemia intermedia: 8 years' follow-up in Egypt","volume":"93","author":"El-Beshlawy","year":"2014","journal-title":"Annals of Hematology"},{"issue":"1","key":"10.1002\/14651858.CD013767.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"11","key":"10.1002\/14651858.CD013767.pub2-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1248\/bpb.30.2084","article-title":"Clinical observation on YiSuiShengXue Granule on treating 156 patients with beta-thalassemia major and the molecular mechanism study","volume":"30","author":"Fang","year":"2007","journal-title":"Biological & Pharmaceutical Bulletin"},{"issue":"3","key":"10.1002\/14651858.CD013767.pub2-BIB0054|cit54","first-page":"47","article-title":"Evaluation of novel fetal hemoglobin inducer drugs in treatment of \u03b2-hemoglobinopathy disorders","volume":"7","author":"Fard","year":"2013","journal-title":"International Journal of Hematology, Oncology and Stem Cell Research"},{"issue":"8","key":"10.1002\/14651858.CD013767.pub2-BIB0055|cit55","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004450.pub3","article-title":"Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia","author":"Fisher","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD013767.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1182\/blood.V87.3.887.bloodjournal873887","article-title":"Hydroxyurea increases hemoglobin F levels and improves the effectiveness of erythropoiesis in beta-thalassemia\/hemoglobin E disease","volume":"87","author":"Fucharoen","year":"1996","journal-title":"Blood"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD013767.pub2-BIB0057|cit57","first-page":"319","article-title":"Healing of leg ulcers with hydroxyurea in thalassaemia intermedia patients with associated endocrine complications","volume":"2","author":"Gamberini","year":"2004","journal-title":"Pediatric Endocrinology Reviews"},{"key":"10.1002\/14651858.CD013767.pub2-BIB0058|cit58","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime)"},{"issue":"10","key":"10.1002\/14651858.CD013767.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1021\/jf803489p","article-title":"Bergamot (Citrus bergamia Risso) fruit extracts as gamma-globin gene expression inducers: phytochemical and functional perspectives","volume":"57","author":"Guerrini","year":"2009","journal-title":"Journal of Agricultural and Food Chemistry"},{"issue":"7414","key":"10.1002\/14651858.CD013767.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD013767.pub2-BIB0061|cit61","unstructured":"Higgins JP Altman DG Sterne JA Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017). Cochrane, 2017 Available from training.cochrane.org\/handbook\/archive\/v5.2"},{"key":"10.1002\/14651858.CD013767.pub2-BIB0062|cit62","unstructured":"Higgins JP Eldridge S Li T Chapter 23: Including variants on randomized trials. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"issue":"4","key":"10.1002\/14651858.CD013767.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/(SICI)1096-8652(199912)62:4<221::AID-AJH4>3.0.CO;2-R","article-title":"Hydroxyurea and sodium phenylbutyrate therapy in thalassemia intermedia","volume":"62","author":"Hoppe","year":"1999","journal-title":"American Journal of Hematology"},{"issue":"1-2","key":"10.1002\/14651858.CD013767.pub2-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cca.2009.06.019","article-title":"Response to hydroxyurea in beta thalassemia major and intermedia: experience in western India","volume":"407","author":"Italia","year":"2009","journal-title":"Clinica Chimica Acta: International Journal of Clinical Chemistry"},{"issue":"9","key":"10.1002\/14651858.CD013767.pub2-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1007\/s00277-018-3357-y","article-title":"Efficacy of decitabine as haemoglobin F inducer in HbE\/\u03b2-thalassemia","volume":"97","author":"Kalantri","year":"2018","journal-title":"Annals of Hematology"},{"issue":"3","key":"10.1002\/14651858.CD013767.pub2-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3109\/08880011003639952","article-title":"Adverse effects of hydroxyurea in \u03b2-thalassaemia intermedia patients: 10 years' experience","volume":"27","author":"Karimi","year":"2010","journal-title":"Pediatric Hematology and Oncology"},{"issue":"5","key":"10.1002\/14651858.CD013767.pub2-BIB0067|cit67","first-page":"1550","article-title":"Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I\/II trial. Pediatric Hydroxyurea Group","volume":"94","author":"Kinney","year":"1999","journal-title":"Blood"},{"issue":"5","key":"10.1002\/14651858.CD013767.pub2-BIB0068|cit68","first-page":"65","article-title":"Hemoglobinopathies: a longitudinal study over four decades","volume":"107","author":"Kohne","year":"2010","journal-title":"Deutsches Arzteblatt International"},{"issue":"31-2","key":"10.1002\/14651858.CD013767.pub2-BIB0069|cit69","first-page":"532","article-title":"Hemoglobinopathies: clinical manifestations, diagnosis, and treatment","volume":"108","author":"Kohne","year":"2011","journal-title":"Deutsches Arzteblatt International"},{"issue":"2","key":"10.1002\/14651858.CD013767.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/03630269.2013.869229","article-title":"Report on patients with non transfusion-dependent beta-thalassemia major being treated with hydroxyurea attending the Thalassemia Research Center, Sari, Mazandaran Province, Islamic Republic of Iran in 2013","volume":"38","author":"Kosaryan","year":"2014","journal-title":"Hemoglobin"},{"issue":"9","key":"10.1002\/14651858.CD013767.pub2-BIB0071|cit71","first-page":"3851","article-title":"Beta-thalassemia treatment passing through natural fetal hemoglobin inducers","volume":"4","author":"Kumari","year":"2011","journal-title":"Journal of Pharmacy Research"},{"key":"10.1002\/14651858.CD013767.pub2-BIB0072|cit72","unstructured":"Lefebvre C Glanville J Briscoe S Littlewood A Marshall C Metzendorf MI Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD013767.pub2-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"657056","DOI":"10.1093\/ecam\/neq022","article-title":"The ethanol extract of fructus trichosanthis promotes fetal hemoglobin production via p38 MAPK activation and ERK inactivation in K562 cells","volume":"2011","author":"Li","year":"2011","journal-title":"Evidence-Based Complementary and Alternative Medicine: eCAM"},{"key":"10.1002\/14651858.CD013767.pub2-BIB0074|cit74","unstructured":"Li T Higgins JP Deeks JJ Chapter 5: Collecting data. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD013767.pub2-BIB0075|cit75","doi-asserted-by":"publisher","first-page":"7468979","DOI":"10.1155\/2016\/7468979","article-title":"Radix Astragali stimulates p38MARK phosphorylation in pediatric patients with \u03b2-thalassemia","volume":"2016","author":"Lu","year":"2016","journal-title":"Evidence-Based Complementary and Alternative Medicine"},{"key":"10.1002\/14651858.CD013767.pub2-BIB0076|cit76","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1378\/chest.100.2.470","article-title":"Effects of heart rate and pulmonary artery pressure on doppler pulmonary artery acceleration time in experimental acute pulmonary hypertension","volume":"100","author":"Mallery","year":"1991","journal-title":"Chest"},{"issue":"1","key":"10.1002\/14651858.CD013767.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2141.2006.06002.x","article-title":"Treatment with hydroxycarbamide for intermedia thalassaemia: decrease of efficacy in some patients during long-term follow up","volume":"133","author":"Mancuso","year":"2006","journal-title":"British Journal of Haematology"},{"issue":"5","key":"10.1002\/14651858.CD013767.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1751-553X.2007.00965.x","article-title":"Effect of hydroxyurea on extramedullary haematopoiesis in thalassaemia intermedia: case reports and literature review","volume":"30","author":"Meo","year":"2008","journal-title":"International Journal of Laboratory Hematology"},{"issue":"40","key":"10.1002\/14651858.CD013767.pub2-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1016\/j.biocel.2008.04.024","article-title":"Histone deacetylase inhibitors and hemoglobin F induction in \u03b2-thalassemia","volume":"11","author":"Migliaccio","year":"2008","journal-title":"International Journal of Biochemistry & Cell Biology"},{"issue":"6","key":"10.1002\/14651858.CD013767.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2471\/BLT.06.036673","article-title":"Global epidemiology of haemoglobin disorders and derived service indicators","volume":"86","author":"Modell","year":"2008","journal-title":"Bulletin of the World Health Organization"},{"key":"10.1002\/14651858.CD013767.pub2-BIB0081|cit81","unstructured":"Ministry of Health of the People's Republic of China Guiding principle of clinical research on new drugs (Part 2) Ministry of Health, China 1995 137 8"},{"issue":"2","key":"10.1002\/14651858.CD013767.pub2-BIB0082|cit82","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1182\/blood-2011-09-382408","article-title":"Fetal hemoglobin levels and morbidity in untransfused patients with beta-thalassemia intermedia","volume":"119","author":"Musallam","year":"2012","journal-title":"Blood"},{"issue":"12","key":"10.1002\/14651858.CD013767.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1182\/blood-2012-10-408021","article-title":"Clinical experience with fetal hemoglobin induction therapy in patients with b-thalassemia","volume":"121","author":"Musallam","year":"2013","journal-title":"Blood"},{"issue":"6","key":"10.1002\/14651858.CD013767.pub2-BIB0084|cit84","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3324\/haematol.2012.066845","article-title":"Non-transfusion-dependent thalassemias","volume":"98","author":"Musallam","year":"2013","journal-title":"Haematologica"},{"issue":"2-3","key":"10.1002\/14651858.CD013767.pub2-BIB0085|cit85","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000243791","article-title":"The role of hepcidin in iron metabolism","volume":"122","author":"Nemeth","year":"2009","journal-title":"Acta Haematologica"},{"key":"10.1002\/14651858.CD013767.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"123257","DOI":"10.1155\/2014\/123257","article-title":"Natural remedies for the treatment of beta-thalassemia and sickle cell anemia-current status and perspectives in fetal hemoglobin reactivation","volume":"2014","author":"Ng","year":"2014","journal-title":"International Scholarly Research Notices"},{"issue":"3","key":"10.1002\/14651858.CD013767.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00439-009-0770-2","article-title":"A genome-wide association identified the common genetic variants influence disease severity in beta-thalassemia\/hemoglobin E","volume":"127","author":"Nuinoon","year":"2010","journal-title":"Human Genetics"},{"issue":"10","key":"10.1002\/14651858.CD013767.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1182\/blood-2011-03-341909","article-title":"A pilot study of subcutaneous decitabine in \u03b2-thalassemia","volume":"118","author":"Olivieri","year":"2011","journal-title":"Blood"},{"issue":"5","key":"10.1002\/14651858.CD013767.pub2-BIB0089|cit89","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3324\/haematol.10842","article-title":"Liver iron concentrations and urinary hepcidin in beta-thalassemia","volume":"92","author":"Origa","year":"2007","journal-title":"Haematologica"},{"issue":"13","key":"10.1002\/14651858.CD013767.pub2-BIB0090|cit90","doi-asserted-by":"publisher","first-page":"4640","DOI":"10.1182\/blood-2002-02-0353","article-title":"Short-chain fatty acid derivatives induce fetal globin expression and erythropoiesis in vivo","volume":"100","author":"Pace","year":"2002","journal-title":"Blood"},{"key":"10.1002\/14651858.CD013767.pub2-BIB0091|cit91","unstructured":"Page MJ Higgins JP Sterne JA Chapter 13: Assessing risk of bias due to missing results in a synthesis. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"issue":"12","key":"10.1002\/14651858.CD013767.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1182\/blood-2013-11-538470","article-title":"A phase 2 trial of HQK-1001 in HbE-\u03b2 thalassemia demonstrates HbF induction and reduced anemia","volume":"123","author":"Patthamalai","year":"2014","journal-title":"Blood"},{"issue":"2","key":"10.1002\/14651858.CD013767.pub2-BIB0093|cit93","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/s0022-3476(67)80410-4","article-title":"Life-span of the fetal red blood cell","volume":"70","author":"Pearson","year":"1967","journal-title":"Journal of Pediatrics"},{"issue":"7","key":"10.1002\/14651858.CD013767.pub2-BIB0094|cit94","doi-asserted-by":"publisher","first-page":"667","DOI":"10.2174\/138920011796504536","article-title":"L-carnitine - metabolic functions and meaning in humans life","volume":"12","author":"Pekala","year":"2011","journal-title":"Current Drug Metabolism"},{"issue":"1","key":"10.1002\/14651858.CD013767.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V74.1.454.454","article-title":"Sodium butyrate enhances fetal globin gene expression inerythroid progenitors of patients with Hb SS and beta thalassemia","volume":"74","author":"Perrine","year":"1989","journal-title":"Blood"},{"issue":"8","key":"10.1002\/14651858.CD013767.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1177\/0091270010379810","article-title":"Evaluation of safety and pharmacokinetics of sodium 2,2 dimethylbutyrate, a novel short chain fatty acid derivative, in a phase 1, double-blind, placebo-controlled, single-dose, and repeat-dose studies in healthy volunteers","volume":"51","author":"Perrine","year":"2011","journal-title":"Journal of Clinical Pharmacology"},{"issue":"8147","key":"10.1002\/14651858.CD013767.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(79)92175-5","article-title":"Iron absorption and loading in beta-thalassaemia intermedia","volume":"2","author":"Pippard","year":"1979","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD013767.pub2-BIB0098|cit98","doi-asserted-by":"publisher","first-page":"696","DOI":"10.3324\/haematol.2012.074492","article-title":"Hydroxyurea responsiveness in \u03b2-thalassemic patients is determined by the stress response adaptation of erythroid progenitors and their differentiation propensity","volume":"98","author":"Pourfarzad","year":"2013","journal-title":"Haematologica"},{"issue":"9","key":"10.1002\/14651858.CD013767.pub2-BIB0099|cit99","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002202.pub3","article-title":"Hydroxyurea (hydroxycarbamide) for sickle cell disease","author":"Rankine-Mullings","year":"2022","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD013767.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/ajh.23725","article-title":"A double-blind, placebo-controlled phase II study of the efficacy and safety of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease","volume":"89","author":"Reid","year":"2014","journal-title":"American Journal of Hematology"},{"issue":"10","key":"10.1002\/14651858.CD013767.pub2-BIB0101|cit101","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1007\/s00277-018-3395-5","article-title":"Clinical trial on the effects of thalidomide on hemoglobin synthesis in patients with moderate thalassemia intermedia","volume":"97","author":"Ren","year":"2018","journal-title":"Annals of Hematology"},{"key":"10.1002\/14651858.CD013767.pub2-BIB0102|cit102","unstructured":"Review Manager (RevMan 5) Nordic Cochrane Centre, The Cochrane Collaboration 2014"},{"issue":"5","key":"10.1002\/14651858.CD013767.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2141.2010.08397.x","article-title":"Desensitization to hydroxycarbamide following long-term treatment of thalassaemia intermedia as observed in vivo and in primary erythroid cultures from treated patients","volume":"151","author":"Rigano","year":"2010","journal-title":"British Journal of Haematology"},{"issue":"2","key":"10.1002\/14651858.CD013767.pub2-BIB0104|cit104","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1046\/j.1365-2141.2001.02746.x","article-title":"Resveratrol, a natural dietary phytoalexin, possesses similar properties to hydroxyurea towards erythroid differentiation","volume":"113","author":"Rodrigue","year":"2001","journal-title":"British Journal of Haematology"},{"issue":"5","key":"10.1002\/14651858.CD013767.pub2-BIB0105|cit105","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1182\/blood.V91.5.1533","article-title":"A bioavailability and pharmacokinetic study of oral and intravenous hydroxyurea","volume":"91","author":"Rodriguez","year":"1998","journal-title":"Blood"},{"issue":"1","key":"10.1002\/14651858.CD013767.pub2-BIB0106|cit106","doi-asserted-by":"publisher","first-page":"a011643","DOI":"10.1101\/cshperspect.a011643","article-title":"The switch from fetal to adult hemoglobin","volume":"3","author":"Sankaran","year":"2013","journal-title":"Cold Spring Harbour Perspective Medicine"},{"key":"10.1002\/14651858.CD013767.pub2-BIB0107|cit107","unstructured":"Sch\u00fcnemann HJ Vist GE Higgins JP Santesso N Deeks JJ Glasziou P Chapter 15: Interpreting results and drawing conclusions. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD013767.pub2-BIB0108|cit108","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing 'Summary of findings' tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"issue":"2","key":"10.1002\/14651858.CD013767.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1182\/blood.V90.2.891","article-title":"Valproic acid and augmentation of fetal hemoglobin in individuals with and without sickle cell disease","volume":"90","author":"Selby","year":"1997","journal-title":"Blood"},{"issue":"9","key":"10.1002\/14651858.CD013767.pub2-BIB0110|cit110","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010517.pub3","article-title":"Splenectomy for people with thalassaemia major or intermedia","author":"Sharma","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD013767.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"e0153767","DOI":"10.1371\/journal.pone.0153767","article-title":"Chemical inhibition of histone deacetylases 1 and 2 induces fetal hemoglobin through activation of GATA2","volume":"11","author":"Shearstone","year":"2016","journal-title":"PLOS One"},{"issue":"10","key":"10.1002\/14651858.CD013767.pub2-BIB0112|cit112","first-page":"598","article-title":"Reference criteria for differentiation of deficiency syndromes in traditional Chinese medicine","volume":"6","author":"Shen","year":"1986","journal-title":"Journal of Integrated Traditional Chinese and Western Medicine"},{"key":"10.1002\/14651858.CD013767.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1196\/annals.1345.031","article-title":"Single and combination drug therapy for fetal hemoglobin augmentation in hemoglobin E-beta 0-thalassemia: considerations for treatment","volume":"1054","author":"Singer","year":"2005","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"3","key":"10.1002\/14651858.CD013767.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1365-2141.2005.05768.x","article-title":"Fetal haemoglobin augmentation in E\/beta(0) thalassaemia: clinical and haematological outcome","volume":"131","author":"Singer","year":"2005","journal-title":"British Journal of Haematology"},{"issue":"6","key":"10.1002\/14651858.CD013767.pub2-BIB0115|cit115","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/ajh.21699","article-title":"The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: a 17.5 year follow-up","volume":"85","author":"Steinberg","year":"2010","journal-title":"American Journal of Hematology"},{"issue":"2","key":"10.1002\/14651858.CD013767.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/pbc.24178","article-title":"Hydroxyurea for the treatment of sickle cell disease: efficacy, barriers, toxicity, and management in children","volume":"59","author":"Strouse","year":"2012","journal-title":"Pediatric Blood Cancer"},{"issue":"1","key":"10.1002\/14651858.CD013767.pub2-BIB0117|cit117","first-page":"e2009004","article-title":"Thalassaemia intermedia: an update","volume":"1","author":"Taher","year":"2009","journal-title":"Mediterranean Journal of Hematology and Infectious Diseases"},{"issue":"10","key":"10.1002\/14651858.CD013767.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1182\/blood-2009-09-243154","article-title":"Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study","volume":"115","author":"Taher","year":"2010","journal-title":"Blood"},{"issue":"11","key":"10.1002\/14651858.CD013767.pub2-BIB0119|cit119","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1080\/14712598.2021.1968825","article-title":"Luspatercept for \u03b2-thalassemia: beyond red blood cell transfusions","volume":"21","author":"Taher","year":"2021","journal-title":"Expert Opinion on Biological Therapy"},{"key":"10.1002\/14651858.CD013767.pub2-BIB0120|cit120","first-page":"14","volume-title":"Guidelines for Management of Non Transfusion Dependent Thalassemia (NTDT)","author":"Taher","year":"2018"},{"key":"10.1002\/14651858.CD013767.pub2-BIB0121|cit121","first-page":"30","volume-title":"Guidelines for Management of Non Transfusion Dependent Thalassemia (NTDT)","author":"Taher","year":"2018"},{"issue":"5","key":"10.1002\/14651858.CD013767.pub2-BIB0122|cit122","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1073\/pnas.0711566105","article-title":"Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia","volume":"105","author":"Uda","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1002\/14651858.CD013767.pub2-BIB0123|cit123","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0011-2240(02)00124-4","article-title":"Biochemical stabilization enhances red blood cell recovery and stability following cryopreservation","volume":"45","author":"Wagner","year":"2002","journal-title":"Cryobiology"},{"issue":"4","key":"10.1002\/14651858.CD013767.pub2-BIB0124|cit124","first-page":"258","article-title":"Observations on after-effect duration of kidney-nourishing and marrow-replenishing therapy on 58 cases of Mediterranean anemia","volume":"29","author":"Wang","year":"2009","journal-title":"Journal of Traditional Chinese Medicine (Chung i Tsa Chih Ying Wen Pan)"},{"key":"10.1002\/14651858.CD013767.pub2-BIB0125|cit125","doi-asserted-by":"crossref","DOI":"10.1002\/9780470696705","volume-title":"The Thalassaemia Syndrome","author":"Weatherall","year":"2001"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013767.pub2-BIB0126|cit126","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/S0268-960X(12)70003-6","article-title":"The definition and epidemiology of non-transfusion-dependent thalassemia","volume":"26","author":"Weatherall","year":"2012","journal-title":"Blood Reviews"},{"key":"10.1002\/14651858.CD013767.pub2-BIB0127|cit127","unstructured":"World Health Organization The World Health Organization Quality of Life (WHOQOL) www.who.int\/mental_health\/publications\/whoqol\/en\/"},{"issue":"5","key":"10.1002\/14651858.CD013767.pub2-BIB0128|cit128","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1182\/blood-2002-08-2617","article-title":"Induction of fetal hemoglobin expression by the histone deacetylase inhibitor apicidin","volume":"101","author":"Witt","year":"2003","journal-title":"Blood"},{"key":"10.1002\/14651858.CD013767.pub2-BIB0129|cit129","unstructured":"World Bank country and lending groups datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519-world-bank-country-and-lending-groups"},{"issue":"8","key":"10.1002\/14651858.CD013767.pub2-BIB0130|cit130","doi-asserted-by":"publisher","first-page":"661","DOI":"10.7326\/0003-4819-130-8-199904200-00013","article-title":"Disclosure of researcher contributions: a study of original research articles in The Lancet","volume":"130","author":"Yank","year":"1999","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD013767.pub2-BIB0131|cit131","volume-title":"Standard of Diagnosis and Therapeutic Effect of Hematopathy","author":"Zhang","year":"2007"},{"key":"10.1002\/14651858.CD013767.pub2-BIB0132|cit132","first-page":"173","volume-title":"Guiding Principle of Clinical Research on Chinese New Herbal Medicines","author":"Zheng","year":"2002"},{"issue":"6","key":"10.1002\/14651858.CD013767.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1182\/blood-2003-07-2475","article-title":"Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease","volume":"103","author":"Zimmerman","year":"2004","journal-title":"Blood"},{"issue":"3","key":"10.1002\/14651858.CD013767.pub2-BIB0134|cit134","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011579","article-title":"Hydroxyurea for reducing blood transfusion in non-transfusion dependent beta thalassaemias","author":"Foong","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD013767.pub2-BIB0135|cit135","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011579.pub2","article-title":"Hydroxyurea for reducing blood transfusion in non-transfusion dependent beta thalassaemias","author":"Foong","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T02:33:26Z","timestamp":1697423606000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD013767.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Cystic Fibrosis and Genetic Disorders Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,1,13]]},"references-count":135,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd013767.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,13]]}}}